Novanta Inc - Company Profile
Powered by 
All the sales intelligence you need on Novanta Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Novanta Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Novanta Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Novanta Inc (Novanta) is a global supplier of core technology solutions for original equipment manufacturers (OEMs) in the medical, life sciences, and advanced industrial sectors. The company's primary activities involve providing technology expertise and competencies in precision medicine and manufacturing, medical solutions, and robotics and automation. It offers laser sources and beam delivery technologies for electronics, industrial, medical, and scientific applications. Novanta’s technology drives various industrial applications such as semiconductor manufacturing, laser materials processing, laser additive manufacturing, robotics, and automation and metrology. The company offers medical technologies under JADAK, NDS Surgical Imaging, and Photo Research brands. Its precision motion products include Applimotion, microe, and Westwind among others. The company serves original equipment manufacturers (OEM) in medical and advanced industrial markets. It operates across the North America, Asia, and Europe. Novanta is headquartered in Bedford, MA, the US.
Headquarters
United States of America
Address
125 Middlesex Turnpike, Bedford, Massachusetts, 01730-1409
Website
www.novanta.com
Telephone
1 781 2665700
No of Employees
3,000
Industry
Industrial Goods and Machinery
Ticker Symbol & Exchange
NOVT (NASD)
Revenue (2024)
$980.6M
3.3%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-16%
(2024 vs 2023)
Market Cap*
$5.8B
Net Profit Margin (2024)
XYZ
-18.7%
(2024 vs 2023)
* As of and is in US$
Products and Services
| Products | Brands |
|---|---|
| Medical Devices: | Ingenia |
| Insufflators | Reach Technology |
| Endoscopic Pumps | Photo Research |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In June, the company signed an agreement to acquire Riverpoint Medical from Arlington Capital Partners, a private investment firm. |
| 2026 | Contracts/Agreements | In March, the company joined the NVIDIA Halos AI Systems Inspection Lab to collaborate on validating the safety and certification of its robotics technologies. |
| 2025 | Contracts/Agreements | In September, the company partners with cognex partner to transform life sciences with advanced machine vision solutions |
Competitor Comparison
| Key Parameters | Novanta Inc | Siemens AG | Renishaw Plc | Allient Inc | Electro Scientific Industries Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | Germany | United Kingdom | United States of America | United States of America |
| City | Bedford | Munich | Wotton-Under-Edge | Amherst | Beaverton |
| State/Province | Massachusetts | - | England | New York | Oregon |
| No. of Employees | 3,000 | 317,000 | 5,342 | 2,478 | 667 |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Matthijs Glastra | Chairman; Chief Executive Officer | Executive Board | 2021 | 57 |
| Robert Buckley | Chief Financial Officer | Senior Management | 2011 | 52 |
| John Burke | Chief Accounting Officer | Senior Management | 2024 | - |
| Sarah Betadam | Chief Information Security Officer; Chief Information Officer | Senior Management | 2021 | - |
| Chuck Ravetto | Co-Chief Operating Officer - Automation Enabling Technologies | Senior Management | 2022 | 55 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer